Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Balloul

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1989
Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigenI Wolowczuk, C Auriault, H Gras-Masse, et al.
Virology|July 13, 2000
Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strainD Spehner, R Drillien, F Proamer, et al.
Gene Therapy|May 16, 2008
Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virusJ Foloppe, J Kintz, N Futin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
Analysis of T and B cell epitopes of the Schistosoma mansoni P28 antigen in the rat model by using synthetic peptidesC Auriault, H Gras-Masse, I Wolowczuk, et al.
Molecular and Biochemical Parasitology|June 1, 1990
Molecular cloning and tissue distribution of a 26-kilodalton Schistosoma mansoni glutathione S-transferaseF Trottein, M P Kieny, C Verwaerde, et al.
Nature|March 12, 1987
Molecular cloning of a protective antigen of schistosomesJ M Balloul, P Sondermeyer, D Dreyer, et al.
Vaccine|September 19, 2007
An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responsesA Fournillier, E Gerossier, A Evlashev, et al.
Cancer Immunology, Immunotherapy : CII|January 12, 2000
MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccinesB Acres, V Apostolopoulos, J M Balloul, et al.
Cancer Gene Therapy|October 25, 2008
Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapyC Tosch, M Geist, C Ledoux, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|January 1, 1994
Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancerJ M Balloul, R B Acres, M Geist, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1989
Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigenI Wolowczuk, C Auriault, H Gras-Masse, et al.
Virology|July 13, 2000
Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strainD Spehner, R Drillien, F Proamer, et al.
Gene Therapy|May 16, 2008
Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virusJ Foloppe, J Kintz, N Futin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
Analysis of T and B cell epitopes of the Schistosoma mansoni P28 antigen in the rat model by using synthetic peptidesC Auriault, H Gras-Masse, I Wolowczuk, et al.
Molecular and Biochemical Parasitology|June 1, 1990
Molecular cloning and tissue distribution of a 26-kilodalton Schistosoma mansoni glutathione S-transferaseF Trottein, M P Kieny, C Verwaerde, et al.
Nature|March 12, 1987
Molecular cloning of a protective antigen of schistosomesJ M Balloul, P Sondermeyer, D Dreyer, et al.
Vaccine|September 19, 2007
An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responsesA Fournillier, E Gerossier, A Evlashev, et al.
Cancer Immunology, Immunotherapy : CII|January 12, 2000
MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccinesB Acres, V Apostolopoulos, J M Balloul, et al.
Cancer Gene Therapy|October 25, 2008
Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapyC Tosch, M Geist, C Ledoux, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|January 1, 1994
Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancerJ M Balloul, R B Acres, M Geist, et al.
Pageof 3